|
Other folks with Campath?
Hey Lisa Z!
Thanks for that reply. It sounds like Campath was really a great choice in your case. I've made contact (left a voicemail) with the team at NIH.
Clinicaltrials.gov indicates they are still recruiting, so I figured I'd at least explore the option. I notice MD Anderson also has a Campath trial underway, though the protocol is significantly different -- and tough if you don't live 'round there.
If you don't mind my asking, is your MDS hypocellular, with Trisomy 8 and/or PNH clone. Those, along with age, seem to be the key predictors of success with immunosuppressants for MDS in general and I notice they are looking for that sort of profile in the Campath trial at NIH.
Any of you other MDS folks had Campath?
Greg H
__________________
Greg, 59, dx MDS RCMD Int-1 03/10, 8+ & Dup1(q21q31). NIH Campath 11/2010. Non-responder. Tiny telomeres. TERT mutation. Danazol at NIH 12/11. TX independent 7/12. Pancreatitis 4/15. 15% blasts 4/16. DX RAEB-2. Beginning Vidaza to prep for MUD STC. Check out my blog at www.greghankins.com
|